Despoina D. Gianniou

Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy

M. Dimopoulos, I. Trougakos, E. Kastritis, 2021, American journal of hematology.

High Clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome.

A. Scorilas, I. Trougakos, A. Sklirou, 2019, Clinical biochemistry.

Inhibition of jasmonate-mediated plant defences by the fungal metabolite higginsianin B

I. Trougakos, R. O’Connell, D. Gasperini, 2019, bioRxiv.

High mRNA Expression Levels of Heat Shock Protein Family B Member 2 (HSPB2) Are Associated with Breast Cancer Patients’ Relapse and Poor Survival

A. Scorilas, I. Trougakos, A. Sklirou, 2022, International journal of molecular sciences.

Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model

I. Trougakos, O. Tsitsilonis, F. Rizzi, 2021, Aging.

Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report

M. Dimopoulos, A. Scorilas, T. Sphicopoulos, 2020, Life.

Non‐lethal proteasome inhibition activates pro‐tumorigenic pathways in multiple myeloma cells

H. Overkleeft, M. Dimopoulos, L. Alexopoulos, 2019, Journal of cellular and molecular medicine.

SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response

M. Dimopoulos, A. Scorilas, T. Sphicopoulos, 2021, Vaccines.

Neolignan Kadsurenin F Modulates Proteostatic Pathways and Possesses Potent Anti-Inflammatory Properties.

I. Trougakos, S. Schwaiger, Z. Evangelakou, 2024, Chemistry & biodiversity.